Valuation: Novartis AG

Market Cap 30TCr 26TCr 24TCr 22TCr 42TCr 28,62000Cr 42TCr 2,86100Cr 1,10900Cr 14,43800Cr 1,12700Cr 1,10200Cr 47,82200Cr P/E 2026 *
22.4x
P/E 2027 * 19.1x
Enterprise Value 33TCr 29TCr 27TCr 24TCr 46TCr 31,73700Cr 46TCr 3,17200Cr 1,22900Cr 16,01100Cr 1,24900Cr 1,22200Cr 53,03000Cr EV / Sales 2026 *
5.77x
EV / Sales 2027 * 5.35x
Free-Float
91.66%
Yield 2026 *
2.77%
Yield 2027 * 2.89%
1 day-0.90%
1 week+0.05%
Current month+0.46%
1 month+0.22%
3 months+7.38%
6 months-0.72%
Current year+16.04%
1 week 124.7
Extreme 124.7
128.68
1 month 121.02
Extreme 121.02
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 96.03
Extreme 96.03
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
17/02/26 Sell 30,743 0.0015%
10/02/26 Sell 7,500 0.0004%
09/02/26 Sell 30,160 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
-0.90%+0.05%+25.57%+41.75% 30TCr
-3.59%-7.10%+61.60%+114.83% 1,06000Cr
-1.15%-1.25%+52.98%+62.41% 65TCr
-1.09%-1.15%+26.18%+79.22% 46TCr
-1.47%+0.24%+42.09%+42.09% 37TCr
-1.94%+1.53%+3.05%+13.24% 26TCr
-0.43%-0.46%+52.06%+71.75% 24TCr
-0.93%+1.84%-13.11%-52.28% 21TCr
-0.46%+0.33%+29.05%+92.67% 18TCr
-0.95%+0.21%+13.56%-22.21% 16TCr
Average -1.29%-0.11%+29.30%+44.35% 38.92TCr
Weighted average by Cap. -1.77%-1.87%+39.30%+64.24%

Financials

2026 *2027 *
Net sales 5.76TCr 4.95TCr 4.64TCr 4.24TCr 8.01TCr 5,49800Cr 8.04TCr 55TCr 21TCr 2,77400Cr 22TCr 21TCr 9,18800Cr 6.13TCr 5.26TCr 4.94TCr 4.51TCr 8.51TCr 5,84800Cr 8.55TCr 58TCr 23TCr 2,95000Cr 23TCr 23TCr 9,77100Cr
Net income 1.4TCr 1.2TCr 1.12TCr 1.03TCr 1.94TCr 1,33100Cr 1.95TCr 13TCr 5.15TCr 67TCr 5.24TCr 5.12TCr 2,22300Cr 1.55TCr 1.33TCr 1.25TCr 1.14TCr 2.15TCr 1,47900Cr 2.16TCr 15TCr 5.73TCr 75TCr 5.82TCr 5.69TCr 2,47100Cr
Net Debt 3.27TCr 2.8TCr 2.63TCr 2.4TCr 4.54TCr 3,11700Cr 4.56TCr 31TCr 12TCr 1,57200Cr 12TCr 12TCr 5,20800Cr 2.78TCr 2.39TCr 2.24TCr 2.05TCr 3.86TCr 2,65300Cr 3.88TCr 27TCr 10TCr 1,33900Cr 10TCr 10TCr 4,43300Cr
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
26/26/26 CHF 127.18 -0.90% 14,81,053
25/26/25 CHF 128.34 +1.25% 17,29,051
24/26/24 CHF 126.76 -0.52% 16,58,623
21/26/21 CHF 127.42 +0.85% 27,06,020
20/26/20 CHF 126.34 -0.61% 18,56,746
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
157.87USD
Average target price
154.32USD
Spread / Average Target
-2.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock